Akero Therapeutics Free Cash Flow (Quarterly) Insights

Akero Therapeutics Inc (AKRO)

27.35 -2.41 (-8.10%) USD | NASDAQ | Nov 15, 14:48

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	-70.42M
June 30, 2024	-58.45M
March 31, 2024	-35.14M
December 31, 2023	-48.63M
September 30, 2023	-49.72M
June 30, 2023	-22.39M
March 31, 2023	-24.63M
December 31, 2022	-25.51M
September 30, 2022	-24.62M
June 30, 2022	-19.51M
March 31, 2022	-22.88M
December 31, 2021	-26.70M
September 30, 2021	-14.61M
June 30, 2021	-20.03M

Date	Value
March 31, 2021	-18.35M
December 31, 2020	-23.40M
September 30, 2020	-13.65M
June 30, 2020	-22.58M
March 31, 2020	-11.32M
December 31, 2019	-11.65M
September 30, 2019	-13.21M
June 30, 2019	-5.322M
March 31, 2019	-5.444M
December 31, 2018	-2.075M
September 30, 2018	-1.961M
June 30, 2018	-5.251M
March 31, 2018	-0.338M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-70.42M

Minimum

Sep 2024

-11.32M

Maximum

Mar 2020

-28.21M

Average

-23.14M

Median

Free Cash Flow (Quarterly) Benchmarks